Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

ONT-380 vs. Placebo + Capecitabine & Trastuzumab in Pts w/ Pretx Unresec Locally Avd or Met HER2+ BC

Protocol: OSU-16196

Full Title

Phase 2 Randomized, Double-Blinded, Controlled Study of ONT-380 vs. Placebo in Combination with Capecitabine and Trastuzumab in Patients with Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Carcinoma